Cardiac tumors

Cardiac tumors are tumors in any part of the heart. MeSH says they include primary cardiac tumors and metastatic tumors to the heart, and that by interfering with normal heart function they can cause symptoms including heart failure, heart rhythm problems or embolism. A 2024 review says cardiac tumors are rare, that most are asymptomatic and found incidentally, and that treatment options and outlook depend on the subtype, the size of the tumor and where it is.

Also called Heart neoplasms · Heart tumors

  • Condition
  • In this atlas

Overview

Technical summary

MeSH Heart Neoplasms (D006338, exact): Cardiac Tumors is an entry term of the descriptor's preferred concept (term T682178 in the concept record M0009959, term lookup on 2026-11-18). The description rests on the MeSH scope note and on a 2024 review under a CC BY licence (Brazilian Journal of Cardiovascular Surgery). The review's prevalence figures, tumor types, imaging methods and survival data are not repeated here. The evidence is descriptive and comes from a narrative review, with no trial data.

Burden

No burden claims are published.

Claims and evidence

Context People with tumors of the heart (narrative review)

Recipient
Recipient not specified
Population
People with primary or metastatic tumors of the heart, as the review describes them. The review also discusses benign and malignant tumors separately.
Care setting
Clinical and surgical care, as described in the review.
Geography
Not stated for the review as a whole.
Life stage
Not restricted by the source. This record makes no statement about pregnancy, newborns or children.
Gestational age
Not reported
Postnatal age
Not reported
Follow-up
Not applicable (a description of a condition).
Eligibility: 1 inclusion criterion; exclusion criteria not stated
Included
  • Having a tumor of the heart
Excluded
None stated
  • Description Evidence synthesis Certainty not assessed

    MeSH describes cardiac tumors as tumors in any part of the heart, including primary cardiac tumors and metastatic tumors to the heart, whose interference with normal cardiac function can cause symptoms including heart failure, cardiac arrhythmias or embolism. A 2024 narrative review (Brazilian Journal of Cardiovascular Surgery) says cardiac tumors are rare and encompass a variety of presentations, that the majority are asymptomatic and found incidentally, and that treatment options and prognosis vary highly depending on the subtype, tumor size and location. It says surgical resection is usually the first-line therapy, except for cardiac lymphomas.

    Applies to Recipient not specified People with tumors of the heart (narrative review)

    Certainty method
    Not assessed
    Limitations
    A narrative review and a thesaurus scope note, with no study data. The review's prevalence figures, tumor types, imaging methods and survival data are not repeated. The statement about surgery is what the review says in its abstract, not advice on treatment or on who should have an operation.
    Last checked
    2026-11-18
    Next evidence check due
    Not scheduled
    Sources and citations (7)
    1. Supports MeSH scope note for descriptor D006338 (Heart Neoplasms)

      Dataset · U.S. National Library of Medicine · Edition MeSH linked-data record of the preferred concept M0009959 of descriptor D006338, fetched 2026-11-18. The scope note is on this concept record, not on the descriptor record. · MeSH: M0009959

      Locator
      scopeNote.@value, sentence 1
      How it applies
      MeSH scope note: tumors in any part of the heart.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      ad2af768212e95eca808ed56134d530a29e965c94012c248257934ce4d167d1e
      Reuse basis
      The NLM web policies page (sha256 c8b7026b5c3fcfd1b0cb88755077f6a99a5f2159eecd42b0e7d1a5ad9b30ec55, hash only) says works produced by the U.S. government are not subject to copyright protection in the United States and asks users to acknowledge NLM as the source. The NLM MeSH terms and conditions page (sha256 f33b14141a5b6c8a2b1464c751dbdbb0a0d476c913851bf2a8c3d5c14b1afce7, hash only) asks redistributors to maintain current data or to make known that their copy may not reflect the most current data. This copy was fetched on 2026-11-18 and may not reflect the most current data. The raw bytes are committed in the atlas repository.
    2. Supports MeSH scope note for descriptor D006338 (Heart Neoplasms)

      Dataset · U.S. National Library of Medicine · Edition MeSH linked-data record of the preferred concept M0009959 of descriptor D006338, fetched 2026-11-18. The scope note is on this concept record, not on the descriptor record. · MeSH: M0009959

      Locator
      scopeNote.@value, sentence 2
      How it applies
      MeSH scope note: primary and metastatic tumors.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      ad2af768212e95eca808ed56134d530a29e965c94012c248257934ce4d167d1e
      Reuse basis
      The NLM web policies page (sha256 c8b7026b5c3fcfd1b0cb88755077f6a99a5f2159eecd42b0e7d1a5ad9b30ec55, hash only) says works produced by the U.S. government are not subject to copyright protection in the United States and asks users to acknowledge NLM as the source. The NLM MeSH terms and conditions page (sha256 f33b14141a5b6c8a2b1464c751dbdbb0a0d476c913851bf2a8c3d5c14b1afce7, hash only) asks redistributors to maintain current data or to make known that their copy may not reflect the most current data. This copy was fetched on 2026-11-18 and may not reflect the most current data. The raw bytes are committed in the atlas repository.
    3. Supports MeSH scope note for descriptor D006338 (Heart Neoplasms)

      Dataset · U.S. National Library of Medicine · Edition MeSH linked-data record of the preferred concept M0009959 of descriptor D006338, fetched 2026-11-18. The scope note is on this concept record, not on the descriptor record. · MeSH: M0009959

      Locator
      scopeNote.@value, sentence 3
      How it applies
      MeSH scope note: symptoms can include heart failure, arrhythmias or embolism.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      ad2af768212e95eca808ed56134d530a29e965c94012c248257934ce4d167d1e
      Reuse basis
      The NLM web policies page (sha256 c8b7026b5c3fcfd1b0cb88755077f6a99a5f2159eecd42b0e7d1a5ad9b30ec55, hash only) says works produced by the U.S. government are not subject to copyright protection in the United States and asks users to acknowledge NLM as the source. The NLM MeSH terms and conditions page (sha256 f33b14141a5b6c8a2b1464c751dbdbb0a0d476c913851bf2a8c3d5c14b1afce7, hash only) asks redistributors to maintain current data or to make known that their copy may not reflect the most current data. This copy was fetched on 2026-11-18 and may not reflect the most current data. The raw bytes are committed in the atlas repository.
    4. Supports Cardiac Tumors: Review

      Publication · Brazilian Journal of Cardiovascular Surgery · Edition PMC Open Access subset full-text XML, from NCBI E-utilities (Brazilian Journal of Cardiovascular Surgery, 2024), fetched 2026-11-18. A narrative or literature review. Used only for how the review describes cardiac tumors in general: rarity, how they present and what shapes treatment; its prevalence figures, tumor-type tables and survival data are not used. · PMCID: PMC11262154 · PMID: 39038269 · DOI: 10.21470/1678-9741-2023-0405

      Locator
      Abstract, sentence 1
      How it applies
      Cardiac tumors are rare.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      8eac5a30b48b5b972f6a5735034ce46749e701193d70ecdc22002f8c1227f899
      Reuse basis
      PMC Open Access subset article under the Creative Commons Attribution 4.0 licence (https://creativecommons.org/licenses/by/4.0/). The article's own license element states the licence. The XML is committed unaltered, with the citation and licence kept in the file. The raw file is committed in the atlas repository.
    5. Supports Cardiac Tumors: Review

      Publication · Brazilian Journal of Cardiovascular Surgery · Edition PMC Open Access subset full-text XML, from NCBI E-utilities (Brazilian Journal of Cardiovascular Surgery, 2024), fetched 2026-11-18. A narrative or literature review. Used only for how the review describes cardiac tumors in general: rarity, how they present and what shapes treatment; its prevalence figures, tumor-type tables and survival data are not used. · PMCID: PMC11262154 · PMID: 39038269 · DOI: 10.21470/1678-9741-2023-0405

      Locator
      Introduction, para 2, sentence 1
      How it applies
      Most are asymptomatic and found incidentally.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      8eac5a30b48b5b972f6a5735034ce46749e701193d70ecdc22002f8c1227f899
      Reuse basis
      PMC Open Access subset article under the Creative Commons Attribution 4.0 licence (https://creativecommons.org/licenses/by/4.0/). The article's own license element states the licence. The XML is committed unaltered, with the citation and licence kept in the file. The raw file is committed in the atlas repository.
    6. Supports Cardiac Tumors: Review

      Publication · Brazilian Journal of Cardiovascular Surgery · Edition PMC Open Access subset full-text XML, from NCBI E-utilities (Brazilian Journal of Cardiovascular Surgery, 2024), fetched 2026-11-18. A narrative or literature review. Used only for how the review describes cardiac tumors in general: rarity, how they present and what shapes treatment; its prevalence figures, tumor-type tables and survival data are not used. · PMCID: PMC11262154 · PMID: 39038269 · DOI: 10.21470/1678-9741-2023-0405

      Locator
      Abstract, sentence 3
      How it applies
      Treatment and prognosis vary with subtype, size and location.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      8eac5a30b48b5b972f6a5735034ce46749e701193d70ecdc22002f8c1227f899
      Reuse basis
      PMC Open Access subset article under the Creative Commons Attribution 4.0 licence (https://creativecommons.org/licenses/by/4.0/). The article's own license element states the licence. The XML is committed unaltered, with the citation and licence kept in the file. The raw file is committed in the atlas repository.
    7. Supports Cardiac Tumors: Review

      Publication · Brazilian Journal of Cardiovascular Surgery · Edition PMC Open Access subset full-text XML, from NCBI E-utilities (Brazilian Journal of Cardiovascular Surgery, 2024), fetched 2026-11-18. A narrative or literature review. Used only for how the review describes cardiac tumors in general: rarity, how they present and what shapes treatment; its prevalence figures, tumor-type tables and survival data are not used. · PMCID: PMC11262154 · PMID: 39038269 · DOI: 10.21470/1678-9741-2023-0405

      Locator
      Abstract, sentence 4
      How it applies
      The review says surgical resection is usually first-line except for lymphomas.
      Retrieved
      Source effective date
      Not reported
      Source state
      Current
      Version fingerprint
      8eac5a30b48b5b972f6a5735034ce46749e701193d70ecdc22002f8c1227f899
      Reuse basis
      PMC Open Access subset article under the Creative Commons Attribution 4.0 licence (https://creativecommons.org/licenses/by/4.0/). The article's own license element states the licence. The XML is committed unaltered, with the citation and licence kept in the file. The raw file is committed in the atlas repository.

Record details

Record id
cardio:cardiac-tumors
Content hash
c13287363165226c0844cdee75a96eeff8d0b8f92b598ec2a993d850b01ef31b